Hajime Sakai
Fundador en Napigen, Inc. .
Fortuna: 688 123 $ al 31/05/2024
Perfil
Hajime Sakai has founded Napigen, Inc. in 2016 and currently holds the titles of President, Chief Executive Officer & Director.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SHINTO PAINT CO., LTD.
1.07% | 30/09/2023 | 332 000 ( 1.07% ) | 266 201 $ | 31/05/2024 |
TOWNNEWS-SHA CO., LTD.
0.89% | 30/06/2023 | 49 500 ( 0.89% ) | 242 547 $ | 31/05/2024 |
| 31/12/2023 | 243 000 ( 1.30% ) | 179 375 $ | 31/05/2024 |
Cargos activos de Hajime Sakai
| Empresas | Cargo | Inicio |
|---|---|---|
Napigen, Inc.
 Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Fundador | 01/01/2016 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Process Industries |
- Bolsa de valores
- Insiders
- Hajime Sakai
